301234SZSE
🚨 Material Event

Announcement on Abnormal and Severe Abnormal Fluctuations in Stock Trading

Wuzhou Medical Co., Ltd.··3 pages

✨ AI Summary

Anhui Hongyu Wuzhou Medical Device Co., Ltd. announces abnormal stock trading fluctuations. The stock price has risen significantly over two and four trading days, exceeding market and industry averages. The company confirms normal operations and no undisclosed material information, advising investors to invest rationally.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 301234 Securities Abbreviation: Wuzhou Medical Announcement No.: 2026-031

Anhui Hongyu Wuzhou Medical Device Co., Ltd.

Announcement on Abnormal and Severe Abnormal Fluctuations in Stock Trading

The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

Special Reminder:

  1. Anhui Hongyu Wuzhou Medical Device Co., Ltd. (hereinafter referred to as the "Company") has experienced abnormal and severe abnormal fluctuations in its stock trading. The cumulative deviation value of the closing price increase in two consecutive trading days (July 24, 2026, and July 27, 2026) exceeded 30%, and the cumulative deviation value of the closing price increase in four consecutive trading days (July 22, 2026, to July 27, 2026) reached 108.38% (exceeding 100%). According to the "Trading Rules of Shenzhen Stock Exchange," this constitutes abnormal and severe abnormal fluctuations in stock trading.

  2. As of July 27, 2026, according to the latest data from China Securities Index Co., Ltd., the rolling P/E ratio for the industry category "C35101020 Medical Consumables" to which the Company belongs is 31.07 times, and the static P/E ratio is 30.02 times. As of July 27, 2026, the Company's dynamic P/E ratio is 148.86 times, and the static P/E ratio is 253.74 times. The Company's P/E ratio is significantly higher than the average level of "C35101020 Medical Consumables."

  3. The Company is mainly engaged in the research, development, manufacturing, and sales of disposable sterile infusion medical devices, as well as the integrated supply of other diagnostic, nursing, and related medical products. After self-examination, the Company's current production and operation activities are normal. Except for the information already disclosed, there have been no major changes in the Company's recent operating conditions or internal and external operating environment. The Company kindly reminds investors to invest rationally and pay attention to investment risks.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.